Bernstein Liebhard LLP Announces An Investigation Concerning Impax Laboratories, Inc.

      Bernstein Liebhard LLP Announces An Investigation Concerning Impax
                              Laboratories, Inc.

PR Newswire

NEW YORK, June 6, 2013

NEW YORK, June 6, 2013 /PRNewswire/ --Bernstein Liebhard LLP today announced
that it is investigating whether the Board of Directors of Impax Laboratories,
Inc. (NASDAQ: IPXL) ("Impax" or the "Company"), in violation of its fiduciary
duties, allowed Impax to be harmed by failing to maintain proper Good
Manufacturing Practices at the Company's Hayward, California facility during
2011 and 2013. In March 2013, the U.S. Food and Drug Administration ("FDA"),
after completing an inspection of the Hayward facility, stated that it had
found twelve problems in need of correction. The Company indicated that the
manufacturing deficiencies noted by the FDA would delay Impax's launch of
Rytary, an extended-release drug for treatment of Parkinson's disease.

(Logo: )

If you are interested in discussing your rights as an Impax shareholder and/or
have information relating to the matter, please contact Joseph R. Seidman, Jr.
at (877) 779-1414 or

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and
shareholder rights cases and recovered over $3 billion for its clients. It
has been named to The National Law Journal's "Plaintiffs' Hot List" in each of
the last ten years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible
for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New
York, New York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of Connecticut is Michael S. Bigin. Prior results
do not guarantee or predict a similar outcome with respect to any future

Contact Information
Joseph R. Seidman, Jr.
Bernstein Liebhard LLP
(212) 779-1414

SOURCE Bernstein Liebhard LLP

Press spacebar to pause and continue. Press esc to stop.